Rajesh Patel appointed as CEO of Trivitron Healthcare India IVD business
New Delhi: Medical technology firm Trivitron Healthcare on Monday announced the appointment of Rajesh Patel as Chief Executive Officer of its India in-vitro diagnostics (IVD) business. Patel has around 29 years of experience in the areas of sales, marketing, and business development in the healthcare segment. Trivitron Healthcare said in a statement.
He has held leadership roles in global and Indian healthcare companies and has experience in pharmaceuticals, clinical research, and IVD/medical devices segment, it added.
"In his new role, Patel will be at the helm of the company's IVD business growth and expansion plans," Trivitron Healthcare Chairman and MD G S K Velu said.
Trivitron Healthcare has 13 manufacturing facilities in India, Finland, Turkey, and China that are the United States Food and Drug Administration (USFDA) and CE certified. It distributes medical technology products to 180 countries.
Read also: VB Gopal Krishnan appointed as Neuberg Diagnostics Group CFO
Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.
NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.